Peter Ward

688 total citations
32 papers, 516 citations indexed

About

Peter Ward is a scholar working on Molecular Biology, Surgery and Organic Chemistry. According to data from OpenAlex, Peter Ward has authored 32 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Organic Chemistry. Recurrent topics in Peter Ward's work include Chemical Synthesis and Analysis (7 papers), Cancer Genomics and Diagnostics (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Peter Ward is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Cancer Genomics and Diagnostics (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Peter Ward collaborates with scholars based in United Kingdom, United States and Mexico. Peter Ward's co-authors include L. Weiss, Janet Holmes, Eric Atherton, R. C. Sheppard, István Tóth, J. P. Harlos, William A. Gibbons, E G Erdös, Kengo Nishimura and Brian R. Walker and has published in prestigious journals such as Gut, Hypertension and British Journal of Cancer.

In The Last Decade

Peter Ward

32 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Ward United Kingdom	13	212	93	81	74	61	32	516
Ian F. Dennis United Kingdom	10	173 0.8×	198 2.1×	98 1.2×	34 0.5×	76 1.2×	16	561
R. Dijkman Netherlands	11	385 1.8×	85 0.9×	49 0.6×	60 0.8×	30 0.5×	19	500
Dwight R. Stickney United States	14	174 0.8×	98 1.1×	24 0.3×	54 0.7×	55 0.9×	40	644
H. Hoffman Australia	13	233 1.1×	56 0.6×	24 0.3×	31 0.4×	57 0.9×	26	586
Valdemar Hial Brazil	10	180 0.8×	102 1.1×	34 0.4×	20 0.3×	51 0.8×	18	494
Gary L. Sanford United States	10	226 1.1×	61 0.7×	38 0.5×	23 0.3×	35 0.6×	17	510
E Kasafírek Czechia	13	195 0.9×	162 1.7×	51 0.6×	50 0.7×	86 1.4×	65	474
Himani Sharma India	9	388 1.8×	76 0.8×	37 0.5×	23 0.3×	77 1.3×	11	577
Kam H. Leung United States	14	300 1.4×	153 1.6×	41 0.5×	44 0.6×	29 0.5×	22	814
Keiko Taniguchi Japan	16	281 1.3×	85 0.9×	47 0.6×	13 0.2×	128 2.1×	55	643

Countries citing papers authored by Peter Ward

Since Specialization

Citations

This map shows the geographic impact of Peter Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ward more than expected).

Fields of papers citing papers by Peter Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ward. The network helps show where Peter Ward may publish in the future.

Co-authorship network of co-authors of Peter Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Ward. A scholar is included among the top collaborators of Peter Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Ward. Peter Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tralau-Stewart, Cathy, Richard A. Williamson, Anthony T. Nials, et al.. (2011). GSK256066, an Exceptionally High-Affinity and Selective Inhibitor of Phosphodiesterase 4 Suitable for Administration by Inhalation: In Vitro, Kinetic, and In Vivo Characterization. Journal of Pharmacology and Experimental Therapeutics. 337(1). 145–154. 51 indexed citations

Webster, Scott P., Margaret Binnie, Karen Sooy, et al.. (2010). Modulation of 11β-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles. Bioorganic & Medicinal Chemistry Letters. 20(11). 3265–3271. 22 indexed citations

Knowles, RG, et al.. (2009). In Vitro Characterisation of GSK256066, an Exceptionally High Affinity and Selective Inhibitor of PDE4 Suitable for Topical Administration.. A4581–A4581. 5 indexed citations

Webster, Scott P., Peter Ward, Margaret Binnie, et al.. (2007). Discovery and biological evaluation of adamantyl amide 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(10). 2838–2843. 44 indexed citations

Lundström, Kenneth, et al.. (1997). Effect of single point mutations of the human tachykinin NK1 receptor on antagonist affinity. European Journal of Pharmacology. 337(1). 73–81. 15 indexed citations

Gale, Jeremy D., C. Gardner, Christopher Jordan, et al.. (1996). Towards Understanding the Aetiology and Pathophysiology of the Emetic Reflex: Novel Approaches to Antiemetic Drugs. Oncology. 53(1). 102–109. 30 indexed citations

Hornby, E J, Susan H. Brown, Michael M. Hann, et al.. (1994). Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist. Thrombosis Research. 75(3). 269–284. 5 indexed citations

Hornby, E J, et al.. (1993). Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs. Thrombosis Research. 72(3). 231–245. 11 indexed citations

Tyc, Vida L., et al.. (1993). Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings.. PubMed. 14(4). 236–41. 25 indexed citations

10.

Tóth, István, et al.. (1992). Lipidic Peptides. V: Penicillin and Cephalosporin Acid Conjugates with Increased Lipophilic Character. Journal of Pharmaceutical Sciences. 81(8). 845–848. 11 indexed citations

11.

Tóth, István, et al.. (1992). Lipidic peptides. VIII. Cellular uptake studies of lipidic amino acid, its oligomers and highly lipophilic drug conjugates. International Journal of Pharmaceutics. 79(1-3). 39–45. 8 indexed citations

12.

Hughes, Richard A., et al.. (1991). Lipidic Peptides. Ill: Lipidic Amino Acid and Oligomer Conjugates of Morphine. Journal of Pharmaceutical Sciences. 80(12). 1103–1105. 13 indexed citations

13.

Tóth, István, Richard A. Hughes, Peter Ward, et al.. (1991). Lipidic peptides. IV. Penicillin and cephalosporin amide conjugates with lipidic amino acids and their oligomers. International Journal of Pharmaceutics. 73(3). 259–266. 9 indexed citations

14.

Weiss, L. & Peter Ward. (1987). Lymphogenous and hematogenous metastasis of Lewis lung carcinoma in the mouse. International Journal of Cancer. 40(4). 570–574. 19 indexed citations

15.

Hollanders, D, et al.. (1986). Histochemistry of gastric mucins in smokers and non‐smokers. International Journal of Clinical Practice. 40(2). 74–77. 11 indexed citations

16.

Ward, Peter & L. Weiss. (1985). The effects of single versus triple intravenous injections of B16 melanoma cells on the development of pulmonary tumors in mice. International Journal of Cancer. 36(4). 519–521. 1 indexed citations

17.

Atherton, Eric, R. C. Sheppard, & Peter Ward. (1985). Peptide synthesis. Part 7. Solid-phase synthesis of conotoxin G1. Journal of the Chemical Society Perkin Transactions 1. 2065–2065. 48 indexed citations

18.

Ward, Peter, et al.. (1983). Histochemical changes in mucus in duodenal ulceration.. Gut. 24(10). 909–913. 24 indexed citations

19.

Varani, James, John Wass, Gerald E. Piontek, & Peter Ward. (1981). Chemotactic factor-induced adherence of tumor cells. Cell Biology International Reports. 5(5). 525–530. 9 indexed citations

20.

Ward, Peter. (1964). A SUGGESTED RELATIONSHIP BETWEEN WING SHAPE OF MIGRANTS AND MIGRATORY FAT. Ibis. 106(2). 256–257. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact